May 19, 2026
4 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
ORLANDO — Patients with severe asthma who are typically underrepresented in clinical studies experienced improved outcomes with tezepelumab in the real world, according to a poster presented at the American Thoracic Society Annual Meeting.Quality of life improved for these patients as well, Njira Lugogo, MD, clinical professor of medicine, division of pulmonary and critical care medicine,
May 19, 2026
4 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

ORLANDO — Initiation of biologic treatment for asthma is low despite availability, and adherence is low as well despite its…

ORLANDO — Exercise capacity and quality of life improved for children with chronic respiratory disease with pulmonary…

Tezepelumab treatment may mean asthmatics for whom inhalers are ineffective can reduce or stop taking steroids

ORLANDO — Among hospitalized adults with acute exacerbation of COPD, pegtarazimod improved oxygen utilization and inflammatory…

ORLANDO — Following hospitalization for an exacerbation of interstitial lung disease related to systemic autoimmune rheumatic…

Adults with moderate to severe psoriasis and overweight or obesity were more likely to achieve complete skin clearance plus…

Ad Insights | Care for Adults with Idiopathic Pulmonary Fibrosis or Progressive Pulmonary Fibrosis

Egpa, Fede (AstraZeneca): "Benralizumab riduce anche uso corticosteroidi"

United Therapeutics Corporation Announces ADVANCE OUTCOMES Study of Ralinepag Presented at ATS 2026

Design Therapeutics' Friedreich ataxia data; Vincentage's obesity results from China

UCB digs deeper into Bimzelx’s psoriatic arthritis win over Skyrizi

Granulomatosi eosinofila con poliangite, ok dell’Aifa a nuova terapia

AstraZeneca notches key FDA nod in hypertension, with an approval sweetener for Fasenra too

Immunotherapy could be used to treat depression, early trial suggests